WHAT IS A GOOD SOLID BIOMARKER FOR PARKINSON DISEASE? – (03-28-05)



Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease

Following up on the previous article, the base problem with using a mitochondrial dysfunction/oxidative stress model is that we have not yet identified a good, solid, commercially available marker.

This article helps in that regards in suggesting that 8-OHDG, a marker of oxidative damage to DNA, may be a viable option.  Interestingly and, not surprisingly, the treatment of choice for Parkinson’s, l-dopa, did not affect 8-OHDG levels.

Read entire article here

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: